Literature DB >> 24318593

Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry.

M W M van der Poel1, S Oerlemans, H C Schouten, F Mols, J F M Pruijt, H Maas, L V van de Poll-Franse.   

Abstract

The objective of this study was to compare health-related quality of life (HRQOL) between diffuse large B cell lymphoma (DLBCL) survivors of different age categories (18-59/60-75/76-85 years) and to compare their HRQOL with an age- and sex-matched normative population. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with DLBCL from 1999 to 2010. Patients (n = 363) were invited to complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) questionnaire, and 307 survivors responded (85 %). Data from an age- and sex-matched normative population (n = 596) were used for comparison. DLBCL survivors aged 18-59 years scored better on physical functioning, quality of life, appetite loss and constipation than survivors of 76-85 years old (all p < 0.05). Financial problems more often occurred in survivors aged 18-59 years compared to survivors of 76-85 years old (p < 0.01). Compared to the normative population, DLBCL survivors aged 18-59 years showed worse scores on cognitive and social functioning and on dyspnea and financial problems (p < 0.01, large- and medium-size effects). In survivors of the other age categories, only differences with trivial or small-size effects were found. Although younger DLBCL survivors have better HRQOL than older survivors, the differences found between younger survivors and normative population were the largest. This suggests that having DLBCL has a greater impact on younger than older survivors and that the worse HRQOL observed in older DLBCL survivors in comparison with younger survivors is caused mostly by age itself and not by the disease.

Entities:  

Mesh:

Year:  2013        PMID: 24318593     DOI: 10.1007/s00277-013-1980-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  19 in total

Review 1.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

2.  Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma.

Authors:  Karin Ribi; Stéphanie Rondeau; Felicitas Hitz; Ulrich Mey; Milica Enoiu; Thomas Pabst; Anastasios Stathis; Natalie Fischer; Kerri M Clough-Gorr
Journal:  Support Care Cancer       Date:  2017-04-13       Impact factor: 3.603

3.  Cognitive function and its relationship to other psychosocial factors in lymphoma survivors.

Authors:  Dorothy Krolak; Barbara Collins; Lorelle Weiss; Cheryl Harris; Richard Van der Jagt
Journal:  Support Care Cancer       Date:  2016-11-11       Impact factor: 3.603

4.  Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.

Authors:  Richard T Maziarz; Edmund K Waller; Ulrich Jaeger; Isabelle Fleury; Joseph McGuirk; Harald Holte; Samantha Jaglowski; Stephen J Schuster; Michael R Bishop; Jason R Westin; Stephan Mielke; Takanori Teshima; Veronika Bachanova; Stephen R Foley; Peter Borchmann; Gilles A Salles; Jie Zhang; Ranjan Tiwari; Lida B Pacaud; Qiufei Ma; Constantine S Tam
Journal:  Blood Adv       Date:  2020-02-25

5.  Correlates of common concerns in older cancer survivors of leukemia and lymphoma: results from the WHI LILAC study.

Authors:  Kah Poh Loh; Eric M McLaughlin; Jessica L Krok-Schoen; Oreofe O Odejide; Areej El-Jawahri; Lihong Qi; Aladdin H Shadyab; Lisa G Johnson; Electra D Paskett
Journal:  J Cancer Surviv       Date:  2022-08-18       Impact factor: 4.062

6.  Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis.

Authors:  Christopher S Strouse; Melissa C Larson; Shawna L Ehlers; Kathleen J Yost; Matthew J Maurer; Stephen M Ansell; David J Inwards; Patrick B Johnston; Ivana N Micallef; Brian K Link; Umar Farooq; James R Cerhan; Carrie A Thompson
Journal:  JCO Oncol Pract       Date:  2022-05-20

7.  A meta-analytic review of religious or spiritual involvement and social health among cancer patients.

Authors:  Allen C Sherman; Thomas V Merluzzi; James E Pustejovsky; Crystal L Park; Login George; George Fitchett; Heather S L Jim; Alexis R Munoz; Suzanne C Danhauer; Mallory A Snyder; John M Salsman
Journal:  Cancer       Date:  2015-08-10       Impact factor: 6.860

8.  The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry.

Authors:  Simone Oerlemans; Floortje Mols; Marten R Nijziel; Wobbe P Zijlstra; Jan Willem W Coebergh; Lonneke V van de Poll-Franse
Journal:  J Cancer Surviv       Date:  2014-05-13       Impact factor: 4.442

9.  Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma.

Authors:  Donald L Patrick; Annette Powers; Monika Parisi Jun; Yeonhee Kim; Jacob Garcia; Christine Dehner; David G Maloney
Journal:  Blood Adv       Date:  2021-04-27

10.  Psychological impact of lymphoma on adolescents and young adults: not a matter of black or white.

Authors:  F M Drost; F Mols; S E J Kaal; W B C Stevens; W T A van der Graaf; J B Prins; O Husson
Journal:  J Cancer Surviv       Date:  2016-02-08       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.